Kenneth M Stedman

Title: Kenneth M Stedman: Innovator in Immunogenic Compositions

Introduction

Kenneth M Stedman is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the development of immunogenic compositions that utilize silicified viruses.

Latest Patents

Stedman holds a patent for "Immunogenic compositions comprising silicified virus and methods of use." This patent reveals that viruses coated in silica can retain their infectivity and induce an immune response in an infected host. The silicified virus demonstrates remarkable resistance to desiccation, making it a valuable tool in vaccine development. The patent also describes methods for inducing a virus-specific immune response by administering an effective amount of silicified virus or particles to a subject. Additionally, it outlines methods for enhancing a virus-specific cell-mediated immune response, such as a T cell-mediated immune response, through the use of silicified virus.

Career Highlights

Throughout his career, Kenneth M Stedman has worked with prominent institutions, including Portland State University and Providence Health & Services - Oregon. His research has contributed to advancements in vaccine technology and immunology.

Collaborations

Stedman has collaborated with notable colleagues, including James R Laidler and Keith Sadoon Bahjat. These partnerships have furthered his research and innovation in the field.

Conclusion

Kenneth M Stedman is a pioneering inventor whose work in immunogenic compositions has the potential to impact vaccine development significantly. His innovative approach to utilizing silicified viruses showcases the importance of research in advancing medical science.